tiprankstipranks

Peter Hug Insider Profile

4 Followers
Peter Hug, Director at ADC Therapeutics, holds 182.64K shares in ADC Therapeutics (Ticker: ADCT). Most recently, Peter Hug Sold $1,193 shares of ADC Therapeutics on Jun 18, 2024 for an estimated value of 3.45K.
tipranks
Peter Hug

Peter Hug
ADC Therapeutics (ADCT)
Director

Not Ranked
Peter Hug has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$628K
100.00%
A breakdown of Peter Hug's holdings

Insider Roles

ADC Therapeutics
(ADCT)
Director
Roles that Peter Hug holds in companies

Most Profitable Insider Trade

Stock:
ADC Therapeutics
(ADCT)
Rating:Informative Sell
Date:Jun 18, 2024 - Today
Return:-26.40%
The most profitable trade made by Peter Hug

Peter Hug's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ADC Therapeutics
Jun 18, 2024
Director
Informative Sell
3.45K
$628.30K
Success Rate for
ADCT
0 out of 1 profitable transactions on
ADCT
0%
Average Return for
ADCT
Average return per transaction on
ADCT
-26.40%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 14, 2024
Uninformative Buy
$0.00
-
$0.00
Jun 18, 2024
Informative Sell
$3.45K
-
$2.89
-26.40%
List of latest transactions for each holding click on a transaction to see Peter Hug's performance on stock

Peter Hug insider profile FAQ

What is the percentage of profitable transactions made by Peter Hug?
The percentage of profitable transactions made by Peter Hug is ―.
    What is the average return per transaction made by Peter Hug?
    The average return per transaction made by Peter Hug is ―.
      What stocks does Peter Hug hold?
      Peter Hug holds: ADCT stocks.
        What was Peter Hug’s latest transaction?
        Peter Hug latest transaction was an Informative Sell of $3.45K.
          What was Peter Hug's most profitable transaction?
          Peter Hug’s most profitable transaction was an Informative Sell of ADCT stock on June 18, 2024. The return on the trade was -26.40%.
            What is Peter Hug's role in ADC Therapeutics?
            Peter Hug's role in ADC Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.